Nifty Pharma Today: Performance, Gainers, Losers & Analysis

Updated: 3 Sept 2026 • 4:08 pm

Posted by:

Nifty Pharma Today: Performance, Gainers, Losers & Analysis

Nifty Pharma today closed the session on a softer note, reflecting broad-based weakness across the pharmaceutical pack even though a handful of stocks managed to stay in the green. The index stood at 26,658.65, down 122.05 points or 0.46% from the previous close of 26,780.70. The intraday pattern was notable because the index opened higher at 26,820.80, touched a high of 26,833.70, and then slipped toward a low of 26,627.25 before ending near the day’s lower zone. That price structure suggests sellers gradually gained control after the opening phase.

For users searching Nifty Pharma live, Nifty Pharma performance, Nifty Pharma stocks, and Nifty Pharma gainers and losers, the most important takeaway is simple: the sector was under pressure, and the weakness was not isolated to one or two names. Market breadth was negative, with 14 declining stocks against 6 advancing stocks. In other words, the index fall was supported by the majority of constituents rather than being caused by a single heavyweight alone.

This article breaks down the latest Nifty Pharma movement using only verified price and breadth data. You will find a full sector snapshot, detailed constituent performance, top gainers, top losers, heavyweight stock action, breadth interpretation, short-term trend reading from intraday price behaviour, and a practical view of what investors should monitor next within the pharma pack.

Table of Contents

Nifty Pharma Today: Sector Index Snapshot

Metric	Value
Current Value	26,658.65
Absolute Change	-122.05
Percentage Change	-0.46%
Opening Value	26,820.80
Previous Close	26,780.70
Today's High	26,833.70
Today's Low	26,627.25
Market Status	Closed
Last Updated	3 September 2026 at 4:00:00 PM IST
Market Trend	Bearish

The session tone was mildly bearish rather than deeply negative. Nifty Pharma opened above the previous close, which initially hinted at resilience, but the inability to sustain those gains changed the character of the day. Once the index slipped from the opening region toward the session low, it signalled that selling pressure was stronger than buying support for most of the trading day.

Another important observation is the distance between the day’s high and close. Because the index did not hold near the high and finished closer to the low, the market message was one of intraday fading momentum. For short-term market participants, this kind of structure often indicates that rallies within the session faced supply. For longer-term investors, however, a 0.46% decline is still best read as a single-session pullback rather than a decisive trend reversal by itself.

Why Is Nifty Pharma Moving Today?

Based on the verified market data available for today, the move in Nifty Pharma can be explained by three observable factors. First, the index had negative market breadth. With only 6 stocks advancing and 14 declining, the sector lacked broad participation on the upside. When most constituents are in the red, the index typically struggles to hold opening gains, and that is exactly what happened.

Second, several prominent pharma names ended lower together. Among the important actively tracked and heavyweight names, Sun Pharmaceutical Industries Ltd. fell 0.81%, Cipla Ltd. lost 1.28%, Lupin Ltd. declined 1.08%, Zydus Lifesciences Ltd. slipped 0.97%, and Mankind Pharma Ltd. dropped 0.95%. Even where the percentage declines were not very large individually, the collective pressure across multiple major names weighed on the index.

Third, the strongest gainers did not have enough sector-wide support to offset the losses. Granules India Ltd. rose 2.66%, Gland Pharma Ltd. gained 1.38%, and Ajanta Pharma Ltd. advanced 1.13%. These were healthy individual moves, but because most of the basket remained negative, the positive impact was limited at the index level.

It is important to stay factual here: there is no verified earnings, policy, regulatory, macro, currency, or commodity-specific trigger included in the supplied dataset. So the most reliable interpretation is that today’s decline was primarily a price-and-breadth-driven sector move, led by broad weakness and reinforced by losses in several widely followed pharma counters.

Market Breadth: What the Sector Internals Show

Breadth Metric	Value
Advancing Stocks	6
Declining Stocks	14
Unchanged Stocks	0
Advance-Decline Ratio	0.43
Stocks in Green	30%
Stocks in Red	70%

Market breadth is one of the clearest ways to judge the quality of a sector move. In Nifty Pharma today, breadth was decisively negative. Only 30% of stocks closed higher, while 70% ended lower. An advance-decline ratio of 0.43 means there were fewer than half as many gainers as losers.

This matters because index declines can sometimes be misleading if only one heavyweight stock is down sharply while the rest of the sector remains steady. That was not the case here. Today’s breadth suggests broader participation on the downside. In practical terms, weakness was visible across large, mid-sized, and select other pharma names within the basket.

For traders, negative breadth combined with a close near the lower end of the day’s range usually points to a softer near-term tone. For investors, it indicates caution in interpreting isolated gainers as a sign of full sector strength. A few names did outperform, but the sector as a whole did not show broad bullish confirmation.

Complete Nifty Pharma Constituent Performance

Company	CMP	Today's %	Today's Change	Day Open	Day High	Day Low	Trend
JB Chemicals & Pharmaceuticals Ltd.	2,408.90	-3.87%	-97.10	2,506.00	2,525.50	2,380.00	Bearish
Granules India Ltd.	853.85	2.66%	22.10	837.50	873.50	834.00	Bullish
Torrent Pharmaceuticals Ltd.	4,905.50	-2.12%	-106.50	5,025.00	5,025.00	4,886.50	Bearish
Gland Pharma Ltd.	2,907.90	1.38%	39.50	2,870.00	2,948.00	2,847.60	Bullish
Cipla Ltd.	1,394.70	-1.28%	-18.10	1,414.00	1,415.40	1,389.40	Bearish
Ajanta Pharma Ltd.	3,521.10	1.13%	39.40	3,462.60	3,536.70	3,456.10	Bullish
Lupin Ltd.	2,132.00	-1.08%	-23.20	2,148.00	2,159.90	2,132.00	Bearish
Zydus Lifesciences Ltd.	1,143.00	-0.97%	-11.20	1,154.20	1,157.80	1,130.50	Bearish
Mankind Pharma Ltd.	2,368.80	-0.95%	-22.70	2,390.00	2,390.00	2,355.40	Bearish
Sun Pharmaceutical Industries Ltd.	1,916.00	-0.81%	-15.70	1,932.00	1,936.80	1,913.00	Bearish
Aurobindo Pharma Ltd.	1,637.30	-0.66%	-10.90	1,656.10	1,666.60	1,626.60	Bearish
Natco Pharma Ltd.	838.30	-0.59%	-4.95	843.30	849.95	835.80	Bearish
Abbott India Ltd.	25,945.00	-0.38%	-100.00	26,175.00	26,175.00	25,905.00	Bearish
Divi's Laboratories Ltd.	9,250.00	0.33%	30.00	9,253.00	9,282.00	9,184.00	Positive
Alkem Laboratories Ltd.	5,193.00	-0.33%	-17.00	5,210.00	5,233.50	5,157.00	Bearish
Biocon Ltd.	402.00	0.25%	1.00	402.50	405.70	400.60	Positive
Laurus Labs Ltd.	1,868.50	0.24%	4.50	1,864.90	1,876.60	1,852.60	Positive
Dr. Reddy's Laboratories Ltd.	1,155.00	-0.13%	-1.50	1,162.00	1,164.30	1,155.00	Weak
Glenmark Pharmaceuticals Ltd.	2,459.00	-0.04%	-1.00	2,470.00	2,471.80	2,425.10	Flat to Weak
Ipca Laboratories Ltd.	1,956.10	-0.02%	-0.40	1,959.50	1,978.20	1,907.90	Flat to Weak

The complete constituent list reinforces the broader market breadth reading. The top performer was Granules India Ltd. with a gain of 2.66%, while the worst performer was JB Chemicals & Pharmaceuticals Ltd., down 3.87%.

What stands out is the clustering of losses across several familiar names. While some declines were mild, the combined effect of multiple red closes limited the ability of gainers to change the index direction. At the same time, the positive moves were concentrated in fewer stocks, which is usually a sign of selective buying rather than broad sector accumulation.

Top Gainers in Nifty Pharma Today

Company	Price Change	% Change	Why It Stood Out Today
Granules India Ltd.	22.10	2.66%	Strongest gain among constituents and a clear standout in an otherwise weak session.
Gland Pharma Ltd.	39.50	1.38%	Held gains through the day and outperformed most pharma peers.
Ajanta Pharma Ltd.	39.40	1.13%	Delivered a solid positive move despite negative sector breadth.
Divi's Laboratories Ltd.	30.00	0.33%	A positive close in an important heavyweight name offered some support.
Biocon Ltd.	1.00	0.25%	Modest gain, but still notable in a broadly negative sector session.

The gainers list shows that selective strength still existed inside the sector. Granules India Ltd. was the clearest bright spot, while Gland Pharma Ltd. and Ajanta Pharma Ltd. also posted respectable advances. In addition, Divi's Laboratories Ltd. finishing positive matters because strength in a heavyweight can cushion an index decline even if it cannot fully reverse the direction.

Still, the broader lesson is that isolated strength alone was not enough. The winning names performed well on a relative basis, but the index requires wider participation to sustain an up move. That participation was missing today.

Top Losers in Nifty Pharma Today

Company	Price Change	% Change	Why It Weighed on the Sector
JB Chemicals & Pharmaceuticals Ltd.	-97.10	-3.87%	Sharpest fall in the sector and the biggest downside outlier of the session.
Torrent Pharmaceuticals Ltd.	-106.50	-2.12%	Meaningful decline in a prominent pharma stock added to sector pressure.
Cipla Ltd.	-18.10	-1.28%	Weakness in a major name reinforced the negative tone.
Lupin Ltd.	-23.20	-1.08%	Another key constituent in the red, reducing any support from gainers.
Zydus Lifesciences Ltd.	-11.20	-0.97%	Contributed to broad-based declines across large and mid-sized names.

The losing side was broader and more influential. JB Chemicals & Pharmaceuticals Ltd. saw the steepest percentage drop, while Torrent Pharmaceuticals Ltd. also came under notable selling pressure. Losses in Cipla Ltd., Lupin Ltd., and Zydus Lifesciences Ltd. added to the drag.

When several recognizable sector leaders and liquid names trade lower together, the benchmark index often struggles to recover intraday weakness. That pattern was visible throughout today’s session.

Heavyweight and Most Active Pharma Stocks

The available list of heavyweight and most active pharma stocks was led by Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Mankind Pharma Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Abbott India Ltd., and Aurobindo Pharma Ltd..

This group provides a useful read on institutional attention and sector leadership. Within that basket, only Divi's Laboratories Ltd. posted a positive move of 0.33%, while most others ended in the red. That imbalance is significant because index direction tends to be heavily influenced by the behaviour of larger and more liquid constituents. If the leaders are mostly weak, the sector index usually reflects that softness.

Among these closely watched names, Torrent Pharmaceuticals Ltd. saw one of the sharper declines at 2.12%, while Cipla Ltd., Lupin Ltd., and Mankind Pharma Ltd. also closed lower. That combination helps explain why the index stayed under pressure despite gains in some smaller pockets.

Intraday Trend Analysis for Nifty Pharma

From the available price structure, the short-term intraday trend for Nifty Pharma was bearish. The index opened above the previous close, moved to a session high of 26,833.70, and then drifted downward toward 26,627.25. It finally settled at 26,658.65, much closer to the low than to the high. That closing position is often associated with a market that lost strength as the day progressed.

The trading range for the day was 206.45 points, calculated from the high of 26,833.70 to the low of 26,627.25. The fact that the close came only about 31.40 points above the day’s low suggests that buyers did not stage a meaningful late-session recovery. Meanwhile, the close sat well below the opening price, which indicates that early optimism faded.

Without longer-period moving averages or oscillator values, the most reliable technical interpretation remains price-action based. On that basis, Nifty Pharma showed a failed attempt to hold early gains, followed by broader selling. In the very near term, traders may watch whether the index can reclaim the opening zone in subsequent sessions or whether weakness continues around the lower band formed today.

At a stock level, intraday patterns were mixed. Some gainers such as Granules India Ltd. and Gland Pharma Ltd. maintained constructive price action, while several losers including Torrent Pharmaceuticals Ltd. and JB Chemicals & Pharmaceuticals Ltd. showed distinctly weaker sessions.

Historical Context from Available Session Data

Today’s close of 26,658.65 was lower than yesterday’s close of 26,780.70, resulting in a day-on-day decline of 122.05 points. That makes the immediate historical comparison straightforward: the sector lost ground compared with the prior session.

Although broader period returns are not available in the supplied dataset, the current session itself offers useful context. Nifty Pharma started the day with a positive bias because the opening price was above the previous close. However, by the end of the session, sellers had erased that advantage. This kind of intraday reversal is often more informative than the final percentage change alone, because it shows how sentiment evolved during the day.

For market readers, this means the negative close was not simply the result of a weak opening. Instead, the market weakened after the open, which typically reflects persistent selling across the session. Combined with the 14-to-6 loser-gainer split, that makes today’s fall more meaningful than a flat or indecisive close would have been.

What Should Investors Watch Next in Nifty Pharma?

The next thing to watch is whether market breadth improves. Breadth often tells the story before the headline index change does. If future sessions continue to show more decliners than advancers, the sector may remain under pressure even if the index decline appears modest. On the other hand, if gainers begin to outnumber losers, it would suggest underlying stability is returning.

Investors should also monitor whether today’s top gainers can sustain leadership. Granules India Ltd., Gland Pharma Ltd., and Ajanta Pharma Ltd. stood out positively. If these names continue to advance and are joined by heavyweight stocks, the sector tone could improve materially.

Just as importantly, traders and investors should keep an eye on the heavyweight basket. Weakness in Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Ltd., Mankind Pharma Ltd., and Zydus Lifesciences Ltd. had a larger influence on the index mood today. If these stocks stabilize or turn positive, index performance may improve even without dramatic moves elsewhere.

Finally, today’s intraday high and low create an immediate reference range for market participants. A stronger showing above the upper part of today’s range would indicate improving demand, while repeated trading near the lower zone would suggest that sellers still control the short-term tone.

Key Takeaways

Nifty Pharma closed at 26,658.65, down 122.05 points or 0.46%.
The index opened strong but lost momentum and finished near the day’s low, which signals a bearish intraday tone.
Market breadth was weak: 6 advancers versus 14 decliners, with an advance-decline ratio of 0.43.
Granules India Ltd. was the top gainer at 2.66%, while JB Chemicals & Pharmaceuticals Ltd. was the top loser at 3.87%.
Several important pharma names, including Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Ltd., and Mankind Pharma Ltd. ended lower.
Divi's Laboratories Ltd. was one of the few heavyweight names to post a positive close.
The sector move today was driven most clearly by price action and negative breadth rather than broad-based upside participation.

FAQs on Nifty Pharma Today

1. What is Nifty Pharma today?

Nifty Pharma today closed at 26,658.65, down 122.05 points or 0.46% from the previous close of 26,780.70.

2. Why did Nifty Pharma fall today?

Nifty Pharma fell because the sector showed weak breadth, with 14 declining stocks and only 6 advancing stocks. Losses in several prominent pharma names also weighed on the index.

3. Was Nifty Pharma bullish or bearish today?

The session tone was bearish. The index opened higher but failed to hold gains and closed closer to the day’s low than the high.

4. What was the high and low of Nifty Pharma today?

Nifty Pharma touched a high of 26,833.70 and a low of 26,627.25 during the session.

5. Which stock gained the most in Nifty Pharma today?

Granules India Ltd. was the top gainer in Nifty Pharma today, rising 2.66%.

6. Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals Ltd. was the top loser in Nifty Pharma today, falling 3.87%.

7. How many Nifty Pharma stocks advanced today?

Six Nifty Pharma stocks advanced today.

8. How many Nifty Pharma stocks declined today?

Fourteen Nifty Pharma stocks declined today.

9. What was the advance-decline ratio in Nifty Pharma today?

The advance-decline ratio in Nifty Pharma today was 0.43, indicating weaker breadth.

10. Which major pharma stocks were under pressure today?

Important names that closed lower included Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Ltd., Zydus Lifesciences Ltd., and Mankind Pharma Ltd..

11. Which heavyweight stock supported Nifty Pharma today?

Divi's Laboratories Ltd. supported the sector by closing 0.33% higher.

12. What should investors watch next in Nifty Pharma?

Investors should watch breadth, the performance of heavyweight stocks, and whether today’s gainers can maintain momentum in coming sessions.

Published on 3 September 2026 at 4:07 PM IST

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.